Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine long-term safety in schizophrenia
NCT01104792Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- May 2010
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Forest Laboratories. Started May 2010; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01104792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104792.